REFERENCES
- Giambona A, Passarello C, Renda D, Maggio A. The significance of the Hemoglobin A(2) value in screening for hemoglobinopathies. Clin Biochem. 2009;42(18):1786–1796.
- Dell’Edera D, Pacella E, Epifania AA, et al. Importance of molecular biology in the characterization of β-thalassemia carriers. Eur Rev Med Pharmacol Sci. 2011;15(1):79–86.
- Sabath DE, Greisman HA. A multiplex approach to the molecular diagnosis of β-thalassemia. J Mol Diagn. 2011;13(4):369–370.
- Sivalingam M, Looi ML, Zakaria SZ, et al. Molecular study and genotype/phenotype correlation of β-thalassaemia in Malaysia. Int J Lab Hematol. 2012;34(4):377–382.
- Weatherall DJ, Clegg JB. The Thalassaemia Syndromes, 3rd ed. Oxford: Blackwell Scientific, 1981.
- Kutlar A, Kutlar F, Gu L-G, Mayson SM, Huisman THJ. Fetal hemoglobin in normal adults and β-thalassemia heterozygotes. Hum Genet. 1990;85(1):106–110.
- Rund D, Filon D, Strauss N, Rachmilewitz EA, Oppenheim A. Mean corpuscular volume of heterozygotes for β-thalassemia correlates with the severity of mutations. Blood. 1992;79(1):238–243.
- Stefanis L, Kanavakis E, Traeger-Synodinos J, Tzetis M, Metaxotou-Mavromati A, Kattamis C. Hematologic phenotype of the mutations IVS1-n6 (T→C), IVS1-n110 (G→A), and CD39 (C→T) in carriers of β-thalassemia in Greece. Pediatr Hematol Oncol. 1994;11(5):509–517.
- Bragós IM, Noguera NI, Raviola MA, Milani C. Genética molecular de β talasémicos heterocigotos. Inter-relación con parámetros hematológicos. Rev Cubana Hematol Inmunol Hemoter.2005;21(1):1–11.
- Mamtani M, Jawahirani A, Rughwani V, das K, Kulkarni H. Value of mean corpuscular volume and mean corpuscular haemoglobin in screening of β-thalassemia trait. Acta Haematol. 2006;116(3):223–225.
- Khattak SA, Ahmed S, Anwar J, Ali N, Shaikh KH. Prevalence of various mutations in β thalassaemia and its association with haematological parameters. J Pak Med Assoc. 2012;62(1):40–43.
- Atanasovska B, Bozhinovski G, Chakalova L, Kocheva S, Karanfilski O, Plaseska-Karanfilska D. Molecular diagnostics of β-thalassemia. BJMG. 2012;15(Suppl):61–65.
- Old JM. Screening and genetic diagnosis of haemoglobinopathies. Scand J Clin Lab Invest. 2007;67(1):71–86.
- López-Escribano H, Parera M, Guix P, et al. Balearic archipelago: three islands, three β-thalassemia population patterns. Clin Genet. 2013;83(2):175–180.
- Moreno I, Bolufer P, Perez ML, Barragán E, Sanz MA. Rapid detection of the major Mediterranean β-thalassaemia mutations by real-time polymerase chain reaction using fluorophore-labelled hybridization probes. Br J Haematol. 2002;119(2):554–557.
- Clark BE, Thein SL. Molecular diagnosis of haemoglobin disorders. Clin Lab Haematol. 2004;26(3):159–176.
- Vrettou C, Kanavakis E, Traeger-Synodinos J, et al. Molecular studies of β-thalassemia heterozygotes with raised Hb F levels. Hemoglobin. 2000;24(3):203–220.
- Mosca A, Paleari R, Ivaldi G, Galanello R, Giordano PC. The role of Haemoglobin A(2) testing in the diagnosis of thalassaemias and haemoglobinopathies. J Clin Pathol 2009;62(1):13–17.